Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of irritable bowel syndrome (IBS) that leads to abdominal pain, bloating, and straining. The exact causes are unknown, but research suggests that multiple factors — such as the gut-brain axis, abnormal muscular contractions, gut microbes, and genetics — could play a role in the disease. IBS-C can be managed with dietary modifications, supplements, and prescription medications.

Quick Answer

What it is

Constipation-predominant irritable bowel syndrome (IBS-C) is a subtype of irritable bowel syndrome (IBS) that leads to abdominal pain, bloating, and straining. The exact causes are unknown, but research suggests that multiple factors — such as the gut-brain axis, abnormal muscular contractions, gut microbes, and genetics — could play a role in the disease.

Key findings

  • Grade A: FDA Responder Rate IBS-C (Linaclotide (Linzess))
  • Grade A: Abdominal Pain Relief (Linaclotide (Linzess))
  • Grade A: Overall Response IBS-C (Plecanatide (Trulance))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

  • Supplements Studied:2
2 supps · 4 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

5-10g daily in divided doses, gradually increased; with plenty of water

Soluble fiber that adds bulk and softens stool; best-studied fiber for IBS-C

15 studies | 1,500 participants
10-50 billion CFU daily (Bifidobacterium infantis 35624, B. lactis DN-173 010)

Restore gut microbiome balance; specific strains shown to help IBS symptoms

20 studies | 3,000 participants

Supporting Stack (Tier 2)

180-225mg enteric-coated capsules 2-3 times daily before meals

Antispasmodic that relaxes intestinal smooth muscle; reduces abdominal pain

12 studies | 1,000 participants
300-500mg magnesium citrate or oxide daily

Osmotic laxative effect; also supports muscle relaxation and reduces stress

8 studies | 500 participants
5g daily mixed with liquid

Prebiotic fiber that improves stool consistency and supports beneficial bacteria

8 studies | 400 participants
500-1000mg before bed

Ayurvedic herbal combination with gentle laxative and gut-supportive effects

5 studies | 200 participants
2000-4000 IU daily

Deficiency associated with IBS; supplementation may improve symptoms

6 studies | 400 participants
100-200mg aloe vera latex or 50mL juice daily (short-term)

Contains compounds with laxative effects; may help IBS-C symptoms

4 studies | 200 participants

How It Works

IBS-C is a functional bowel disorder characterized by chronic abdominal pain associated with constipation (hard or lumpy stools, straining, incomplete evacuation, infrequent bowel movements). Unlike regular constipation, IBS-C involves recurring abdominal pain that relates to bowel movements. It affects quality of life significantly and can be frustrating to manage. The gut-brain connection is central to IBS - stress and emotions affect gut function, and gut symptoms affect mood.

CRITICAL: IBS is a diagnosis of exclusion - make sure other conditions (celiac disease, inflammatory bowel disease, thyroid problems, colon cancer in appropriate age groups) have been ruled out. See a doctor for new symptoms, warning signs (blood in stool, unexplained weight loss, family history of colon cancer, onset after age 50, progressive worsening). Treatment often involves a combination of dietary changes (low FODMAP diet can be very helpful), stress management, and sometimes medications (linaclotide, lubiprostone, plecanatide are FDA-approved for IBS-C). These supplements support management alongside these approaches.

* Psyllium Fiber is the best-studied fiber for IBS-C. It's a soluble fiber that forms a gel, adding bulk and softening stool without causing as much gas as insoluble fiber. Start slowly and increase gradually.

* Probiotics help rebalance the gut microbiome. Certain strains like Bifidobacterium infantis 35624 have been specifically shown to help IBS symptoms.

* Peppermint Oil (enteric-coated) is an antispasmodic that relaxes intestinal muscles, reducing cramping and pain. The enteric coating protects it until it reaches the intestines.

* Magnesium has a natural osmotic laxative effect and also helps with stress and muscle relaxation.

* Partially Hydrolyzed Guar Gum is a prebiotic fiber that improves stool consistency with less bloating than some other fibers.

* Triphala is a traditional Ayurvedic formula with gentle laxative effects.

* Vitamin D deficiency is common in IBS patients, and supplementation may improve symptoms.

* Aloe Vera has laxative properties but should be used cautiously and not long-term.

Expected timeline: Fiber and probiotics may take 2-4 weeks to show benefit. Peppermint oil works more quickly for pain relief. Full benefit often requires 4-12 weeks of consistent use.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

A
FDA Responder Rate IBS-C
Phase 3: 33.6-33.7% FDA responders vs 13.9-21.0% placebo (P<0.0001). Dual endpoint: ≥30% pain improvement + ≥1 CSBM increase for ≥50% of weeks. Effect maintained over 26 weeks.
largeImproves
A
Abdominal Pain Relief
Significant improvement in worst abdominal pain scores vs placebo. Pain relief observed within first week. cGMP-mediated visceral analgesia independent of bowel effects. No rebound worsening on discontinuation.
largeImproves
A
Overall Response IBS-C
Phase 3: 30.2% overall responders (3mg) vs 17.8% placebo (P<0.001). Dual endpoint: ≥30% pain reduction + ≥1 CSBM increase for ≥6 of 12 weeks. Consistent across two identical trials (n=2,189).
largeImproves
A
Abdominal Pain IBS-C
Significant reduction in worst abdominal pain vs placebo. ≥30% improvement in pain required for FDA responder endpoint. cGMP-mediated visceral analgesia mechanism.
largeImproves

Research Citations (77)

Linaclotide combined with polyethylene glycol for bowel preparation in colonoscopy: a systematic review and meta-analysis of randomized controlled trials.
(2026)
PMID: 41168471
Efficacy and tolerability of plecanatide for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis.
(2026)
PMID: 41604554
Efficacy and Safety of Linaclotide as an Adjunct to Polyethylene Glycol in Bowel Preparation: A Meta-Analysis.
(2025)
PMID: 40955723
Efficacy and safety of pharmacological therapies for functional constipation in children: a systematic review and meta-analysis.
(2025)
PMID: 41101321
Safety and efficacy of linaclotide as an adjuvant for bowel preparation: A systematic review and meta-analysis.
(2025)
PMID: 41203453
ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years.
(2025)
PMID: 40444524
Management of Chronic Constipation: A Comprehensive Review.
(2025)
PMID: 37952945
Combined linaclotide and polyethylene glycol electrolyte for colonoscopy preparation: a network meta-analysis of 14 randomized controlled trials.
(2025)
PMID: 40528061
Post-marketing safety assessment of constipation drugs: a real-world pharmacovigilance study based on FAERS database.
(2025)
PMID: 39950440
The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
(2025)
PMID: 40471839

Related Conditions